Meribank Biotech Co., Ltd engages in the biotechnology business. It offers handling, testing, and frozen storage of umbilical cord blood, placenta and umbilical cord mesenchymal stem cells, and others, as well as develops new cell drugs. The company is based in Taipei City, Taiwan.
Stock data | 2024 | Change |
---|---|---|
Price | $1.08 | N/A |
Market Cap | $67.62M | N/A |
Shares Outstanding | 62.78M | N/A |
Employees | 0 | N/A |